Stefan Koch
| Titel: | Prof. Dr. med. habil. Dr. phil. |
| Denomination: | Professur für Pathologie |
| Aktuelle Position: | Chefarzt a. D. / Senior Consultant |
| Fachbereich: | Pathologie |
| Adresse: |
Institut für Pathologie
Universitätsklinikum Brandenburg an der Havel Hochstraße 29, Haus 11 14770 Brandenburg an der Havel |
| Telefon: | +49 3381 412531 |
| E-Mail: | stefan.koch@mhb-fontane.de |
| An der MHB seit: | 04.07.2016 |
Publikationen
Meine besten 5 Publikationen:
-
Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F, Hake R, Eidt S, Roggisch J, Heidenreich A, Rieger C, Kastner L, Hallmann S, Koch S, Wirtz RM. Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. Int J Mol Sci. 2022;23(14). http://www.ncbi.nlm.nih.gov/pubmed/35887247?dopt=Citation.
-
Ecke TH, Scislowski M, Hassan N, Saura M, Hallmann S, Koch S, Vuolle S, Malakoutikhah M, Kopra K, Härmä H. Luminophore Chemistry for Detection of Urinary Bladder Cancer - Comparison to Cytology and Urinary Rapid Tests (BTA stat®, NMP22® BladderChek® and UBC® Rapid Test). Anticancer Res. 2022 Nov;42(11):5249-5256. doi: 10.21873/anticanres.16031. PMID: 36288849 https://doi.org/10.21873/anticanres.16031
-
Roggisch J, Ecke T, Koch S. Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer. Urol Oncol. 2019. http://www.ncbi.nlm.nih.gov/pubmed/31521529?dopt=Citation.
-
Meisl CJ, Karakiewicz PI, Einarsson R, Koch S, Hallmann S, Weiß S, Hemdan T, Malmström PU, Styrke J, Sherif A, Hasan MN, Pichler R, Tulchiner G, Palou J, Rodríguez Faba Ó, Hennenlotter J, Stenzl A, Ritter R, Niegisch G, Grunewald CM, Schlomm T, Friedersdorff F, Barski D, Otto T, Gössl A, Arndt C, Esuvaranathan K, Kesavan NR, Zhijiang Z, Kramer MW, Hennig MJP, Ecke TH. Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset. BJU Int. 2021. http://www.ncbi.nlm.nih.gov/pubmed/34928524?dopt=Citation.
-
Ecke TH, Schwaiger D, Nesterov G, Koswig S, Selinski S, Barrett T, Gnanapragasam V, Koch S, Hallmann S.: Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion. Urol Oncol. 2021 Nov;39(11):781.e1-781.e7. doi: 10.1016/j.urolonc.2021.01.008. Epub 2021 Feb 7. PMID: 33563540 https://pubmed.ncbi.nlm.nih.gov/33563540/
Weitere/Alle Publikationen:
https://pubmed.ncbi.nlm.nih.gov/?term=Koch+S&cauthor_id=33563540
